Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension (2015)
- Authors:
- USP affiliated authors: SANTOS, JOSE EDUARDO TANUS DOS - FMRP ; GERLACH, RAQUEL FERNANDA - FORP
- Unidades: FMRP; FORP
- DOI: 10.1016/j.redox.2015.08.017
- Subjects: HIPERTENSÃO; ÓXIDO NÍTRICO; METALOPROTEINASES; FÁRMACOS (SISTEMA CARDIOVASCULAR)
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Redox Biology
- ISSN: 2213-2317
- Volume/Número/Paginação/Ano: v. 6, p. 386-395, 2015
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc-nd
-
ABNT
GUIMARÃES, Danielle A. et al. Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension. Redox Biology, v. 6, p. 386-395, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.redox.2015.08.017. Acesso em: 19 set. 2024. -
APA
Guimarães, D. A., Rizzi, E., Ceron, C. S., Martins-Oliveira, A., Gerlach, R. F., Shiva, S., & Tanus-Santos, J. E. (2015). Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension. Redox Biology, 6, 386-395. doi:10.1016/j.redox.2015.08.017 -
NLM
Guimarães DA, Rizzi E, Ceron CS, Martins-Oliveira A, Gerlach RF, Shiva S, Tanus-Santos JE. Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension [Internet]. Redox Biology. 2015 ; 6 386-395.[citado 2024 set. 19 ] Available from: https://doi.org/10.1016/j.redox.2015.08.017 -
Vancouver
Guimarães DA, Rizzi E, Ceron CS, Martins-Oliveira A, Gerlach RF, Shiva S, Tanus-Santos JE. Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension [Internet]. Redox Biology. 2015 ; 6 386-395.[citado 2024 set. 19 ] Available from: https://doi.org/10.1016/j.redox.2015.08.017 - Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism
- Inibição de metaloproteinases (MMPs) com Doxycycline atenua a embolia pulmonar aguda (EPA)-indutor de hipotensão sistêmica
- Inverse relationship between markers of nitric oxide formation and plasma matrix metalloproteinase-9 levels in healthy volunteers
- Circulating cell-free DNA levels in plasma increase with severity in experimental acute pulmonary thromboembolism
- Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome
- A role for matrix metalloproteinase-9 in the hemodynamic changes following acute pulmonary embolism
- Determinação de gelatinases no fluido gengival em pacientes sadios e com doença periodontal
- Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension
- Metalloproteinase inhibition protects against cardiomyocyte injury during experimental acute pulmonary thromboembolism
- Chronic treatment with nebivolol attenuates the vascular changes in the 2-kidney, 1-clip model of renovascular hypertension
Informações sobre o DOI: 10.1016/j.redox.2015.08.017 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
